Company / Free Cash Flow per Share
Beam Therapeutics Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$3.54
FY2025
5-year range
-$4.26 / -$0.37
FY2021-FY2025
Trend
+16.9%
vs FY2024
Sector context
#161 of 192
Health Care
What the data says
Beam Therapeutics Inc.'s free cash flow per share of $-3.54 is lower than 84% of companies in the Health Care sector (FY2025). Free Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-3.54.
Based on SEC 10-K filings.
-3.54 in FY2025.
Declined from $-2.24 to $-3.54 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 192This company -$3.54 Sector average -$19.84
▼
+82.2% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 16.9% year-over-year.
- Ranks #161 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2022.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.54 | +16.9% |
| FY2024 | -$4.26 | -90.1% |
| FY2023 | -$2.24 | -504.5% |
| FY2022 | -$0.37 | +77.6% |
| FY2021 | -$1.65 | +85.7% |
| FY2020 | -$11.54 | +11.6% |
| FY2019 | -$13.04 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026